Journal of Bioanalysis & Biomedicine

8^th Asian Biologics and Biosimilars Congress

August 10-12, 2017 Beijing, China

Scientific Tracks Abstracts

• Challenges in assessing therapeutic equivalence of nanosimilars

  Beat Fluhmann

  PDF HTML

• Considerations in biosimilars commercialization

  Darius Panaligan

  PDF HTML

• Convergence of regulatory expectations

  Robert Salcedo

  PDF HTML

• From neuromodulation to drug discovery and treatment

  Ulloa L, Morcillo P and Torres-Rosas R

  PDF HTML

• The role of regulatory policies in relation to the local biosimilars production

  Gustavo H Marin

  PDF HTML

• 10 year perspective: Science and commercial power- Battle of the giants in biosimilars

  Richard Littlewood

  PDF HTML

• Biosimilars in the UKs NHS: Attitudes, appetites and acceptance

  Divya Chadha Manek

  PDF HTML

• Comparison of biosimilar registration guidelines between EU and USA

  Frank Cheng

  PDF HTML

• Biosimilars: Challenges in safety and risk management

  Asif Mahmood

  PDF HTML

• Practical considerations in clinical strategy to support the development of biologics device combination products

  Zhaoyang Li

  PDF HTML

• Patients as partners - transforming the delivery of clinical research in the NHS

  Divya Chadha Manek

  PDF HTML

• GMP Compliance: how critical to your success of biological product to the market

  Frank Cheng

  PDF HTML

• Expression of Shiga like toxin (SLT) fused to vascular endothelial growth factor (VEGF) in E. coli for targeting angiogenesis

  Osama O Ibrahim

  PDF HTML